Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes Trial
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine how glucose control in women with GDM treated with metformin and/or insulin influenced pregnancy outcomes. RESEARCH DESIGN AND METHODS: Women randomly assigned to metformin or insulin treatment in the Metformin in Gestational Diabetes (MiG) trial had baseline glucose tolerance test (OGTT) results and A1C documented, together with all capillary glucose measurements during treatment. In the 724 women who had glucose data for analysis, tertiles of baseline glucose values and A1C and of mean capillary glucose values during treatment were calculated. The relationships between maternal factors, glucose values, and outcomes (including a composite of neonatal complications, preeclampsia, and large-for-gestational-age [LGA] and small-for-gestational-age infants) were examined with bivariable and multivariate models. RESULTS: Baseline OGTT did not predict outcomes, but A1C predicted LGA infants (P = 0.003). During treatment, fasting capillary glucose predicted neonatal complications (P < 0.001) and postprandial glucose predicted preeclampsia (P = 0.016) and LGA infants (P = 0.001). Obesity did not influence outcomes, and there was no interaction between glycemic control, randomized treatment, or maternal BMI in predicting outcomes. The lowest risk of complications was seen when fasting capillary glucose was <4.9 mmol/l (mean ± SD 4.6 ± 0.3 mmol/l) compared with 4.9–5.3 mmol/l or higher and when 2-h postprandial glucose was 5.9–6.4 mmol/l (6.2 ± 0.2 mmol/l) or lower. CONCLUSIONS: Glucose control in women with gestational diabetes mellitus treated with metformin and/or insulin is strongly related to outcomes. Obesity is not related to outcomes in this group. Targets for fasting and postprandial capillary glucose may need to be lower than currently recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which fits with other data showing that maternal glycemia relates to birth weight.21–23”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Preeclampsia: An excessive maternal inflammatory response to pregnancy
Redman, C. W. G., Sacks, G. P., & Sargent, I. L. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70239-5 · Cited by 1,840
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310 · cited 1×
“A further study has shown that fluctuating glucose levels have a stronger effect on endothelial function (important in the pathogenesis of preeclampsia [14]) than sustained hyperglycemia (15).”
BackgroundMetformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 2×
“The methodology and outcomes have been published previously (10).”
MethodSelf-citationGestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677 · cited 1×
“A lthough treatment of gestational diabetes mellitus (GDM) has been shown to improve perinatal outcomes (1,2), there is lack of consensus about ideal glucose targets and how other factors, such as fetal abdominal circumference, should influence these targets (3,4).”
BackgroundHyperglycemia and Adverse Pregnancy Outcomes
Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., et al. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000344706.95925.dc · Cited by 479
Langer, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., & Divon, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90371-2 · Cited by 376 · cited 2×
“There was no increase in SGA infants in the lowest glucose tertile, but mean glucose values were above the threshold previously shown to increase risk of SGA infants (9).”
BackgroundOverweight and obese in gestational diabetes: The impact on pregnancy outcome
Langer, O., Yogev, Y., Xenakis, E. M. J., & Brustman, L. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.049 · Cited by 239 · cited 2×
“Obesity has been reported as an independent factor influencing outcome in women with GDM treated with diet but not in those treated with insulin (7,8).”
BackgroundResultDiurnal glycemic profile in obese and normal weight nondiabetic pregnant women
Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., & Langer, O. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.059 · Cited by 168 · cited 1×
“The relationship between postprandial glucose levels and complications may be relevant for obese women without GDM, who have higher postprandial glucose levels and increased rates of preeclampsia and LGA infants compared with lean women (12).”
BackgroundA customised birthweight centile calculator developed for a New Zealand population
McCOWAN, L., STEWART, A. W., FRANCIS, A., & GARDOSI, J. (2004) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2004.00272.x · Cited by 154 · cited 2×
“net), which adjust for sex and gestational age of the infant as well as for maternal height, weight in early pregnancy, ethnic group, and parity (11).”
BackgroundMethodGonzález-Quintero, V. H., Istwan, N. B., Rhea, D. J., Rodriguez, L. I., Cotter, A., Carter, J., Mueller, A., & Stanziano, G. J. (2007) · Diabetes Care · doi:10.2337/dc06-1875 · Cited by 130
Pregnancy outcome in obese and morbidly obese gestational diabetic women
Yogev, Y., & Langer, O. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.03.022 · Cited by 104
Kjos, S. L., & Schaefer-Graf, U. M. (2007) · Diabetes Care · doi:10.2337/dc07-s216 · Cited by 87
Metformin Versus Insulin for the Treatment of Gestational Diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000344705.95925.07 · Cited by 85
Self-citationGoals of Metabolic Management of Gestational Diabetes
Hod, M., & Yogev, Y. (2007) · Diabetes Care · doi:10.2337/dc07-s213 · Cited by 44
Linking the Genetics of Type 2 Diabetes With Low Birth Weight
Meier, J. J. (2009) · Diabetes · doi:10.2337/db09-0225 · Cited by 33
Macrosomic infants are not all equal
SINCLAIR, B. A., Rowan, J., & HAINSWORTH, O. T. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00694.x · Cited by 23
Self-citationRowan, J., Steven, L. U. E. N., Hughes, R. C. E., Sadler, L. C., & McCowan, L. M. E. (2009) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2009.00975.x · Cited by 16 · cited 7×
“Improved pregnancy outcomes have been reported in women achieving these targets compared with those in women who did not (6); the latter group had higher baseline mean BMI and A1C, which may have influenced outcomes.”
BackgroundMethodInfluentialSelf-citation
Cited by
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“Importantly, it has been demonstrated that the diagnostic OGTT values were not the best predictors of outcomes whereas CBG levels during treatment were strongly correlated to adverse pregnancy outcomes (325).”
BackgroundRowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Self-citationMetformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
“In addition, there is an increased risk for neonatal death, still birth and congenital defects [5] resulting from excessive mother-to-fetus glucose transfer [6], [7].”
BackgroundTreatments for gestational diabetes
Alwan, N., Tuffnell, D. J., & West, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003395.pub2 · Cited by 214
Niromanesh, S., Alavi, A., Sharbaf, F. R., Amjadi, N., Moosavi, S., & Akbari, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.031 · Cited by 203
“[6] Rowan JA, Gao W, Hague WM, McIntyre HD.”
Background
Metadata
- Authors
- Rowan, J. A., Gao, W., Hague, W. M., & McIntyre, H. D.
- Affiliations
- Auckland City Hospital (NZ)
- Temple University (US)
- Women's and Children's Hospital (AU)
- Department of Obstetric Medicine, University of Queensland and Mater Health Services, South Brisbane, Queensland, Australia.
- Corresponding author
- Gao, Wanzhen
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-10-21
- Volume
- 33
- Issue
- 1
- Pages
- 9-16
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2797992
- OpenAlex
- W2114195383
- Cited by
- 96
- References
- 20
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 6 · 2018: 10 · 2017: 7 · 2016: 10 · 2015: 9 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Auckland Medical Research Foundation
- Medical Research Council
- National Health and Medical Research Council
- Health Research Council of New Zealand
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, glycemic control, metformin, insulin therapy, capillary blood glucose, HbA1c, fasting blood glucose, postprandial blood glucose, neonatal complications, preeclampsia, large for gestational age, small for gestational age, maternal obesity, glycemic targets
- MeSH terms
- Birth Weight, Female, Gestational Age, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Infant, Newborn, Infant, Small for Gestational Age, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Diabetes, Gestational, Treatment Outcome, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.